The Valley Desk

NCT06067230 · Interventional trial

A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults

Overall registry status Completed

Phase 3

Conditions Respiratory Syncytial Virus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov